Molecular Characterization of Candida Auris
NCT04121871 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 384
Last updated 2020-10-27
Summary
Candida auris is emerging fungal opportunistic pathogen in developing countries. Much studies has been conducted on Candida albicans. there was a dire need to investigate this alarming threat. Our hypothesis is that by recording the patients diagnosed with oropharygneal candidiasis and collecting clinical swab samples from these patients will be fruitful if microbiological isolation, identification and molecular characterization will be done. So this is the first study on C. auris in south punjab, Pakistan. Aim of this study is to collect epidemiological data of C. auris.
Conditions
- Oral Fungal Infection
Interventions
- OTHER
-
No intervention
Not required
Sponsors & Collaborators
-
Islamia University of Bahawalpur
lead OTHER
Principal Investigators
-
Jafi H Shirazi, M.Phil · The Islamia University of Bahawalpur
Eligibility
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-15
- Primary Completion
- 2020-02-29
- Completion
- 2020-02-29
Countries
- Pakistan
Study Locations
More Related Trials
-
Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)
NCT03363841 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections
NCT06680544 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Assessment of Antimicrobial Peptides Against Fungal Infection
NCT05368948 ·Status: UNKNOWN
-
Vulvovaginal Candidiasis in Canadian Females
NCT04930107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis
NCT00056368 ·Status: COMPLETED ·Phase: PHASE3
-
Candida Associated Cytokines in Oral Leukoplakia
NCT04712929 ·Status: COMPLETED
-
Anidulafungin In Treatment Of Candidemia In Asian Subjects
NCT00537329 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability of Flucanazole
NCT04502277 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Oral Candida in Infants and Dietary Type
NCT01438983 ·Status: COMPLETED
-
Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis
NCT01259336 ·Status: COMPLETED ·Phase: PHASE4
-
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
NCT00413218 ·Status: COMPLETED ·Phase: PHASE3
-
Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis
NCT00761267 ·Status: COMPLETED ·Phase: PHASE3
-
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
NCT00095316 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of the Vacucis Candida® Autovaccine
NCT05289375 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis
NCT06194201 ·Status: RECRUITING ·Phase: PHASE2
-
An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris
NCT04148287 ·Status: COMPLETED ·Phase: PHASE2
-
Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom
NCT01202253 ·Status: COMPLETED
-
A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis
NCT01176058 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor
NCT06922344 ·Status: RECRUITING ·Phase: PHASE4
-
A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects
NCT00940017 ·Status: COMPLETED ·Phase: PHASE4
-
Studies of Disorders With Increased Susceptibility to Fungal Infections
NCT01222741 ·Status: RECRUITING
-
Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp
NCT06954493 ·Status: COMPLETED ·Phase: PHASE1
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
NCT02734862 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
NCT00004938 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome
NCT00002112 ·Status: COMPLETED ·Phase: NA